KMPHARMACEUTICAL Co.,Ltd. (KOSDAQ:225430)
South Korea · Delayed Price · Currency is KRW 698.00
+16.00 (2.35%)
At close: Sep 14, 2026
KMPHARMACEUTICAL Ratios and Metrics
Market cap in millions KRW. Fiscal year is January - December.
Millions KRW. Fiscal year is Jan - Dec.
Total Valuation
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 11, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| 3,893 | 15,003 | 19,103 | 27,274 | 44,340 | 62,049 | |
Market Cap Growth | -78.52% | -21.46% | -29.96% | -38.49% | -28.54% | -0.47% |
Enterprise Value | 22,425 | 30,160 | 32,128 | 39,519 | 56,196 | 64,798 |
Last Close Price | 698.00 | 2690.00 | 3425.00 | 4890.00 | 7950.00 | 11125.00 |
Price Ratios
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 11, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
PS Ratio | 0.23 | 0.94 | 1.32 | 1.54 | 2.84 | 2.73 |
PB Ratio | 0.15 | 0.53 | 0.59 | 0.77 | 1.22 | 1.56 |
P/TBV Ratio | 0.15 | 0.53 | 0.59 | 0.77 | 1.22 | 1.56 |
P/FCF Ratio | - | - | - | 20.45 | - | - |
P/OCF Ratio | - | - | - | 18.86 | - | 27.37 |
EV Ratios
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 11, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
EV/Sales Ratio | 1.32 | 1.89 | 2.22 | 2.22 | 3.60 | 2.85 |
EV/EBITDA Ratio | - | - | - | 154.53 | - | 28.07 |
EV/EBIT Ratio | - | - | - | - | - | 74.81 |
EV/FCF Ratio | - | - | - | 29.64 | - | - |
Financial Efficiency
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 11, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Debt / Equity Ratio | 0.70 | 0.56 | 0.43 | 0.35 | 0.37 | 0.24 |
Debt / EBITDA Ratio | - | - | - | 48.67 | - | 4.19 |
Debt / FCF Ratio | - | - | - | 9.34 | - | - |
Net Debt / Equity Ratio | 0.70 | 0.55 | 0.41 | 0.32 | 0.35 | 0.18 |
Net Debt / EBITDA Ratio | -6.87 | -6.08 | -5.30 | 44.67 | -5.60 | 3.03 |
Net Debt / FCF Ratio | -4.84 | -7.69 | -5.55 | 8.57 | -83.90 | -71.33 |
Asset Turnover | 0.36 | 0.34 | 0.29 | 0.35 | 0.30 | 0.44 |
Inventory Turnover | 5.52 | 5.47 | 4.52 | 5.32 | 4.76 | 5.80 |
Quick Ratio | 0.13 | 0.13 | 0.23 | 0.28 | 0.23 | 0.86 |
Current Ratio | 0.28 | 0.32 | 0.51 | 0.50 | 0.51 | 1.32 |
Return on Equity (ROE) | -13.12% | -13.04% | -13.43% | -3.68% | -10.30% | -1.52% |
Return on Assets (ROA) | -4.71% | -4.66% | -4.83% | -1.37% | -4.47% | 1.05% |
Return on Invested Capital (ROIC) | -8.01% | -7.92% | -8.29% | -2.32% | -7.76% | 1.94% |
Return on Capital Employed (ROCE) | -11.30% | -10.30% | -9.70% | -2.90% | -9.60% | 1.90% |
Yields
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 11, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Earnings Yield | -96.87% | -26.45% | -23.94% | -4.84% | -8.85% | -0.98% |
FCF Yield | -98.30% | -13.39% | -12.57% | 4.89% | -0.34% | -0.16% |
Buyback Yield / Dilution | -66.10% | -0.00% | 0.71% | -0.90% | -0.20% | -29.80% |